SE0103668D0 - Method for the treatment of overactive blader - Google Patents

Method for the treatment of overactive blader

Info

Publication number
SE0103668D0
SE0103668D0 SE0103668A SE0103668A SE0103668D0 SE 0103668 D0 SE0103668 D0 SE 0103668D0 SE 0103668 A SE0103668 A SE 0103668A SE 0103668 A SE0103668 A SE 0103668A SE 0103668 D0 SE0103668 D0 SE 0103668D0
Authority
SE
Sweden
Prior art keywords
treatment
compounds
overactive
leaves
disclosed
Prior art date
Application number
SE0103668A
Other languages
English (en)
Swedish (sv)
Inventor
Cathy Dantzman
Keith Herzog
Russell Bialecki
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0103668A priority Critical patent/SE0103668D0/xx
Publication of SE0103668D0 publication Critical patent/SE0103668D0/xx
Priority to CA002465140A priority patent/CA2465140A1/en
Priority to IL16159902A priority patent/IL161599A0/xx
Priority to CNA028266005A priority patent/CN1622806A/zh
Priority to PCT/SE2002/001990 priority patent/WO2003037341A1/en
Priority to BR0213776-3A priority patent/BR0213776A/pt
Priority to KR1020047006519A priority patent/KR20050042211A/ko
Priority to MXPA04004071A priority patent/MXPA04004071A/es
Priority to US10/494,387 priority patent/US20040248914A1/en
Priority to JP2003539684A priority patent/JP2005511561A/ja
Priority to EP02783903A priority patent/EP1450805A1/en
Priority to ZA200403199A priority patent/ZA200403199B/en
Priority to NO20042139A priority patent/NO20042139L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0103668A 2001-11-02 2001-11-02 Method for the treatment of overactive blader SE0103668D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0103668A SE0103668D0 (sv) 2001-11-02 2001-11-02 Method for the treatment of overactive blader
EP02783903A EP1450805A1 (en) 2001-11-02 2002-11-01 Method for the treatment of overactive bladder
PCT/SE2002/001990 WO2003037341A1 (en) 2001-11-02 2002-11-01 Method for the treatment of overactive bladder
IL16159902A IL161599A0 (en) 2001-11-02 2002-11-01 Method for the treatment of over-active bladder
CNA028266005A CN1622806A (zh) 2001-11-02 2002-11-01 用于治疗膀胱活动过度的方法
CA002465140A CA2465140A1 (en) 2001-11-02 2002-11-01 Method for the treatment of overactive bladder
BR0213776-3A BR0213776A (pt) 2001-11-02 2002-11-01 Método e composição farmacêutica para o tratamento ou a prevenção de bexiga superativa ou incontinência urinária em um indivìduo, e, uso de (s)-n-[2-(3,4-diclorofenil)-4-[4-(2-oxoperhidropirimidin- 1-il) piperidino]butil]-n-metilbenzamida ou um sal farmaceuticamente aceitável da mesma
KR1020047006519A KR20050042211A (ko) 2001-11-02 2002-11-01 과활동성 방광의 치료 방법
MXPA04004071A MXPA04004071A (es) 2001-11-02 2002-11-01 Metodo para tratamiento de vejiga hiperactiva.
US10/494,387 US20040248914A1 (en) 2001-11-02 2002-11-01 Method for the treatment of overactive bladder
JP2003539684A JP2005511561A (ja) 2001-11-02 2002-11-01 過活動膀胱の治療のための方法
ZA200403199A ZA200403199B (en) 2001-11-02 2004-04-28 Method for the treatment of overactive bladder.
NO20042139A NO20042139L (no) 2001-11-02 2004-05-25 Fremgangsmate for behandling av hyperaktiv blaere

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103668A SE0103668D0 (sv) 2001-11-02 2001-11-02 Method for the treatment of overactive blader

Publications (1)

Publication Number Publication Date
SE0103668D0 true SE0103668D0 (sv) 2001-11-02

Family

ID=20285870

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0103668A SE0103668D0 (sv) 2001-11-02 2001-11-02 Method for the treatment of overactive blader

Country Status (13)

Country Link
US (1) US20040248914A1 (ja)
EP (1) EP1450805A1 (ja)
JP (1) JP2005511561A (ja)
KR (1) KR20050042211A (ja)
CN (1) CN1622806A (ja)
BR (1) BR0213776A (ja)
CA (1) CA2465140A1 (ja)
IL (1) IL161599A0 (ja)
MX (1) MXPA04004071A (ja)
NO (1) NO20042139L (ja)
SE (1) SE0103668D0 (ja)
WO (1) WO2003037341A1 (ja)
ZA (1) ZA200403199B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121389A1 (en) * 2005-05-10 2006-11-16 Astrazeneca Ab Use of a neurokinin-2 receptor antagonist for treating or preventing detrusor overactivity
US10441620B2 (en) * 2016-09-21 2019-10-15 Wellstrong Biotech Co., Ltd. Method for protection of bladder from damage

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1170417B (de) * 1960-11-08 1964-05-21 Recip Ab Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung
US5382600A (en) * 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
GB9310713D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9505084D0 (en) * 1995-03-14 1995-05-03 Pfizer Ltd Benzamide derivative
GB9922519D0 (en) * 1998-10-07 1999-11-24 Zeneca Ltd Compounds
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
GB9826941D0 (en) * 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence

Also Published As

Publication number Publication date
JP2005511561A (ja) 2005-04-28
BR0213776A (pt) 2004-11-09
ZA200403199B (en) 2005-02-09
US20040248914A1 (en) 2004-12-09
CN1622806A (zh) 2005-06-01
CA2465140A1 (en) 2003-05-08
IL161599A0 (en) 2004-09-27
EP1450805A1 (en) 2004-09-01
WO2003037341A1 (en) 2003-05-08
NO20042139L (no) 2004-06-25
KR20050042211A (ko) 2005-05-06
MXPA04004071A (es) 2004-09-06

Similar Documents

Publication Publication Date Title
WO2004096798A3 (fr) Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
AU2002213336A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
DE60039508D1 (de) Methoden zur behandlung der essstörungen
WO2004021989A3 (en) Imidazolopyridines and methods of making and using the same
ATE510534T1 (de) Naltrexonhydrochlorid-zusammensetzungen
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
WO2007053610A3 (en) Methods of treating atrial fibrillation wtih pirfenidone
HK1068136A1 (en) Muscarinic antagonists
WO2004062613A3 (en) Hiv integrase inhibitors
WO2001098268A3 (en) Piperidine amides as modulators of chemokine receptor activity
NO963731L (no) Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
EA200400734A1 (ru) Способ и композиция для потенциирования действия опиатного анальгетика
WO2004064832A3 (en) Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
WO2006124865A3 (en) Biaryls derivatives useful as modulators of ion channels
BR0012327A (pt) Pirrolidinas e piperidinas neurotróficas, e composições e métodos relacionados
SE0103795D0 (sv) Compounds and method for the treatment of överactive bladder
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
DE60033207D1 (de) Werkzeug zur herstellung von nockenwellen durch einwalzen
SE0103668D0 (sv) Method for the treatment of overactive blader
BRPI0406734A (pt) Composição termiticida, e, método para controlar térmitas
WO2002024727A3 (en) New inhibitors of iapp fibril formation and uses thereof